I am starting to wonder what their endgame is. It seems they want to establish a line of consumer directed test ordering which is efficient, cheap, and easy to find. That may be possible if they can make their technology actually work and work cheaply (including quality controls and proficiency testing and such), or if they manage to convince people that their testing is reliable. I had thought their endgame was to create a new methodology which would be cheaper and faster and more portable, but I'm not sure about that now. There are probably dozens of other companies working on testing that will be faster and more portable. Maybe not cheaper, but that's all relative anyway. Theranos can only undercut the price for so long before they run out of reserves and loans and have to actually start charging enough to make a profit. So if they want to sell their machines to others they obviously have to do a lot of work.
The whole issue of Laboratory Developed Test and the loopholes is an interesting side story. They are claiming that, despite the fact that they are manufacturing hundreds or thousands of analyzers and using them all over the country that their tests are the same thing as other "lab developed tests" which are typically modifications of existing assays like JAK-2 assays or FISH tests or whatever. I really can't see that holding water. That's like if Siemens or Beckmann decided to open up their own labs and say they no longer needed FDA approval because they were lab developed. Would anyone stand for that really? Ultimately though since they are testing for things that are commonly tested for elsewhere, they need to demonstrate that their results are rock solid equivalent of other existing assays. This isn't a new test, these are sodium, platelet counts, bilirubin, all things with known clinical impact and reference ranges. "Simple" tests which have to have reproducible and trusted results. You can't just say "trust us, our results are great" and get away with that.
And I see that they are still blaming criticisms on lab corp and the competition trying to bring them down. I don't understand their public relations at all. They act more like politicians or investment banks, dodging and weaving, being cryptic and hiding data, and blaming haters instead of answering actual questions. They seem to fail to realize that everyone hates politicians and investment banks and no one really trusts them. For certain industries that might be an ok strategy. For health care data that's not ok for most people.